Fig. 4From: Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancerOverall survival rate of lung cancer patients stratified by number of variants in plasma. Patients were divided into groups based on number of variants 0–3 variants (n = 20), 4–9 variants (n = 23), and 10–22 variants (n = 18)Back to article page